• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    'Graft-on-a-Chip' Built to Improve Vascular Graft Success

    Abbott Invests €440 in New Irish Facility

    FDA Approves Guardant Health's NGS-Based Companion Diagnostic

    Reflow Medical Completes DEEPER LIMUS Clinical Trial Enrollment

    NanoVibronix Strengthening its Supply Chain to Address Potential Delays
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cooling and Melting the Pain Away

    What Are the Fundamentals of Go-To-Market Strategy in Medical Devices?

    Minding the Gap: How Harmonizing Quality Systems Pays Off

    Building Strong Partnerships Between Medtech and Surgeon-Learning Platforms

    Four Key Considerations for OEMs Transferring a Product Program
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Concise Engineering

    Xact Wire EDM Corp.

    Cirtec Medical

    Arthur G. Russell Co. Inc., The

    BMP Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Medical Computing: COM Express Processes Real-Time Data at the Edge

    The Importance of Building Successful Supplier Relationships

    The Benefits of Outsourcing Innovation in Medtech Manufacturing

    Patching Healthcare Cybersecurity Risks in the Internet of Medical Things

    Leveraging Open Healthcare Data Standards to Improve Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Concise Engineering

    Xact Wire EDM Corp.

    Cirtec Medical

    Arthur G. Russell Co. Inc., The

    BMP Medical
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Ethicon Compares Gastric Bypass Surgery to Pharmacotherapy in Treating CKD

    Shows efficacy of bariatric surgery in treating major diseases tied to obesity.

    Ethicon Compares Gastric Bypass Surgery to Pharmacotherapy in Treating CKD
    According to the study, gastric bypass surgery is significantly more effective than the best pharmacotherapy in achieving remission of early-stage chronic kidney disease.
    Related CONTENT
    • Breakthrough Device Designation Granted for New Neuromodulation Platform
    • Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech
    • Babson Diagnostics Raises $31 Million in Series B Funding
    • Paragonix Launches Global Registry for Studying Donor Lung Preservation
    • FDA Approves Abbott's Portico with FlexNav TAVR System
    Ethicon07.20.20
    According to an Ethicon-supported randomized clinical trial recently published in JAMA Surgery, which compared the two treatments in patients with type 2 diabetes and obesity (BMI 30 to 35), gastric bypass surgery is significantly more effective than the best pharmacotherapy in achieving remission of early-stage chronic kidney disease (CKD).1
     
    In the MOMS (Microvascular Outcomes after Metabolic Surgery) study, 100 patients were randomly assigned to receive Roux-en-Y gastric bypass surgery (RYGB) or best medical treatment. At the two-year follow-up period, 82% of surgical patients achieved remission early-stage CKD versus a remission rate of 48% in patients only receiving pharmacotherapy. According to the results, there were no differences in serious complications between the two treatment groups (13% each). 
     
    “These findings point to a new treatment paradigm to reverse or prevent early chronic kidney disease progression in patients with diabetes and obesity,” said lead study author Ricardo Cohen, MD, Oswaldo Cruz German Hospital in Sao Paulo, Brazil. “Both patients, and the physicians who treat them for these diseases, should consider metabolic surgery together with medical management as a potentially better option than medical management alone.”
     
    Coauthor Prof. Carel le Roux from University College Dublin in Ireland, further commented that “by treating chronic kidney disease with a metabolic surgery approach we are also able to often place type 2 diabetes and hypertension in remission while allowing patients to maintain 25% weight loss in the long term.” 
     
    The medical community has long known that bariatric surgery is the most effective treatment for obesity, says Ethicon, but three landmark randomized clinical trials – MOMS, STAMPEDE and GATEWAY – all sponsored by Ethicon over the last three years, have helped to further establish surgery as an effective treatment for type 2 diabetes, hypertension and most recently, kidney disease. While previous studies have had similar findings, none were randomized clinical trials. 
     
    “Randomized clinical trials remain the cornerstone of evidence-based medicine, and along with real-world clinical studies, provide the basis for determining the standard of care for healthcare professionals and guiding coverage decisions made by health insurers and policymakers,” said Raymond Fryrear, MD, VP & integrated leader, Pre-Clinical, Clinical and Medical Affairs, Johnson & Johnson. “Ethicon has made a major investment in these kinds of studies as we strive to make bariatric surgery available to all patients who could benefit.”
     
    Other Recent Randomized Clinical Trials on Diabetes and Hypertension
    In STAMPEDE (Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently), Cleveland Clinic researchers found bariatric surgery and intensive medical therapy is a better long-term treatment than intensive medical therapy alone for patients with obesity and type 2 diabetes.2 In the five-year study, over 88% of surgical patients maintained healthy blood glucose levels without the use of insulin and more than a quarter achieved and maintained normal blood glucose levels, compared to just 5% of those on medication alone. The study was published in The New England Journal of Medicine in 2017.
     
    That same year, GATEWAY (GAstric bypass to Treat obEse patients With steAdy hYpertension) was published in Circulation. This study found that bariatric surgery and medical therapy are superior to medical therapy alone in improving or resolving hypertension in patients with obesity.3 Within a month of surgery, 83.7% of gastric bypass patients achieved blood pressure control with at least 30% fewer medications, and within a year, more than half showed remission and required no medications at all. The medical therapy group was not as successful with only 12.8% reducing their use of high blood pressure drugs by 30% and none achieving remission over 12 months. 
     
    According to World Health Organization (WHO) about 650 million people had obesity in 2016.4 Bariatric surgery now has the evidence base to support the conclusion that it effectively reduces the complications of obesity.
     
    References:
    1 https://jamanetwork.com/journals/jamasurgery/article-abstract/2766660
    2 http://www.nejm.org/doi/full/10.1056/NEJMoa1600869
    3 https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.117.032130
    4 https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
    Related Searches
    • Surgical
    • Chronic Disease
    Related Knowledge Center
    • Chronic Disease
    • Surgical
    Suggested For You
    Breakthrough Device Designation Granted for New Neuromodulation Platform Breakthrough Device Designation Granted for New Neuromodulation Platform
    Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech
    Babson Diagnostics Raises $31 Million in Series B Funding Babson Diagnostics Raises $31 Million in Series B Funding
    Paragonix Launches Global Registry for Studying Donor Lung Preservation Paragonix Launches Global Registry for Studying Donor Lung Preservation
    FDA Approves Abbott FDA Approves Abbott's Portico with FlexNav TAVR System
    Improved Outcomes Proven With Insulet’s Omnipod 5 System Improved Outcomes Proven With Insulet’s Omnipod 5 System
    Masimo Launches Single-Patient-Use rainbow SuperSensor in Europe Masimo Launches Single-Patient-Use rainbow SuperSensor in Europe
    Vertigo Treatment Receives FDA Breakthrough Device Designation Vertigo Treatment Receives FDA Breakthrough Device Designation
    Quanta Raises $245 Million in Series D Funding Round Quanta Raises $245 Million in Series D Funding Round
    Know Labs Awarded New Patent for Non-Invasive Diagnostic Tech Platform Know Labs Awarded New Patent for Non-Invasive Diagnostic Tech Platform
    Mayo Clinic, Google Research AI Software Could Boost Brain Stim Devices Mayo Clinic, Google Research AI Software Could Boost Brain Stim Devices
    RonovoRx RonovoRx's RenovoCath Earns New FDA 510(k)
    CE Mark Granted to Expandable, Biodegradable Biliary Stent CE Mark Granted to Expandable, Biodegradable Biliary Stent
    Sectoral Asset Management Invests $9M in Cagent Vascular Sectoral Asset Management Invests $9M in Cagent Vascular
    Aleva Neurotherapeutics Recruits First Patient Into PMCF Study Aleva Neurotherapeutics Recruits First Patient Into PMCF Study

    Related Breaking News

    • Breakthrough Device Designation Granted for New Neuromodulation Platform

      Breakthrough Device Designation Granted for New Neuromodulation Platform

      In a pilot study treating refractory epilepsy with Neuroelectrics’ Starstim platform, patients experienced a 44 percent median reduction in seizure frequency.
      Business Wire 09.22.21

    • Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech

      Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech

      Electroducer Sleeve based on a medical technique called Direct Wire Pacing, which was invented by the company’s founder.
      Electroducer 09.21.21

    • Diagnostics
      Babson Diagnostics Raises $31 Million in Series B Funding

      Babson Diagnostics Raises $31 Million in Series B Funding

      Money will be used to help drive commercialization of customer-first, highly accessible diagnostic blood testing.
      Business Wire 09.20.21


    • Paragonix Launches Global Registry for Studying Donor Lung Preservation

      Paragonix Launches Global Registry for Studying Donor Lung Preservation

      Registry will capture data on how organ preservation and transportation impact patient outcomes in lung transplantation.
      Business Wire 09.20.21

    • Cardiovascular
      FDA Approves Abbott

      FDA Approves Abbott's Portico with FlexNav TAVR System

      Self-expanding TAVR valve features intra-annular (within the native valve) leaflets.
      PR Newswire 09.20.21

    Loading, Please Wait..

    Trending
    • Cardinal Health CEO Mike Kaufmann Steps Down
    • BD Recalls Intraosseous Products Over Multiple Issues
    • Abbott Invests €440 In New Irish Facility
    • Medidata Unveils New Tech To Improve Clinical Trial Oversight
    • Chronic, Infectious Disease Prevalence To Benefit Vital Signs Monitoring Market
    Breaking News
    • 'Graft-on-a-Chip' Built to Improve Vascular Graft Success
    • Abbott Invests €440 in New Irish Facility
    • FDA Approves Guardant Health's NGS-Based Companion Diagnostic
    • Reflow Medical Completes DEEPER LIMUS Clinical Trial Enrollment
    • NanoVibronix Strengthening its Supply Chain to Address Potential Delays
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Parylene Coatings for Medical Device Technologies
    • Nearshoring Trends in Medtech Manufacturing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    SONGWON Industrial Group Reports Strong Q2 Financial Results
    PPG Completes COLORFUL COMMUNITIES Project for Boys & Girls Clubs of Greater Houston
    Paul N. Gardner Now Offers Bacharach Sling Psychrometer
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    'Graft-on-a-Chip' Built to Improve Vascular Graft Success
    Abbott Invests €440 in New Irish Facility
    FDA Approves Guardant Health's NGS-Based Companion Diagnostic
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AskBio Appoints Clinical Ops Executives
    SpectrumX Partners With UK Contract Manufacturer
    GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Arkay Chairman Emeritus Howard Kaneff Has Died
    Nutricosmetics Market to Hit $13.7 Billion by 2030
    Estée Lauder Pledges 100% Electric Fleet of Vehicles by 2030
    Happi

    Latest Breaking News From Happi

    J&J To Stop Global Sales of Talc-Based Products by 2023
    Net Sales Increase 2% for Naples Soap Company in Second Quarter
    Net Revenue Down 12% for Grove Collaborative in Second Quarter
    Ink World

    Latest Breaking News From Ink World

    Heidelberg Enjoys Successful Start to 2022-23 Fiscal Year
    Mimaki Announces New LATAM Website
    Paul N. Gardner Offers Bacharach Sling Psychrometer
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Esko, Constantia Flexibles announce acquisitions and more
    Hybrid Software joins The Flexo Xperience Center
    Flexo Wash LLC and Mike Potter celebrate 20 years
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Focke & Co. to Host Destination: Your Hygiene Hub on August 31
    Exports Dominate Chinese Trade of Tissues, Hygiene Products and Wipes
    Freudenberg to Present Friction Inserts for Wind Energy
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Dental 3D Printing Market is Expanding 20% Annually
    Study Results Released for Abbott's Concussion Blood Test
    Bone Growth Stimulators Market to Top $3B by 2030
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    eMagin Corporation Announces 2Q 2022 Results
    Zebra Technologies’ Emission Reduction Targets Validated by SBTi
    Identiv Delivers Impressive 41% Year-over-Year Growth in RFID Business

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login